Project Frazier 3 Regulatory Clinical Evaluation

NCT03515421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 379

Last updated 2020-09-10

No results posted yet for this study

Summary

Clinical Evaluation of Blood Glucose Monitoring Systems (BGMSs)

Conditions

Interventions

DEVICE

Frazier 3 Verio

In vitro diagnostic device (IVDD)

DEVICE

Frazier 3 UltraPlus

In vitro diagnostic device (IVDD)

Sponsors & Collaborators

  • Institute for Diabetes-Technology GmbH

    collaborator UNKNOWN
  • LifeScan Scotland Ltd

    lead INDUSTRY

Principal Investigators

  • Lorna Stewart · LifeScan Scotland

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-09
Primary Completion
2018-06-18
Completion
2018-06-18

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03515421 on ClinicalTrials.gov